Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …
Endocrine Therapy for Endometrial Cancer: Traditional Approaches and Novel Targets Frontiers
Patients with endometriosis often experience bowel symptoms such as changing stool, abdominal pain and bloating similar to those associated with irritable bowel syndrome. These symptoms reduce quality of life (QoL). …
Poor ovarian response (POR) significantly reduces the success rates of fertility treatments. This study investigates the long-term efficacy and potential complications associated with autologous menstrual blood-derived mesenchymal stromal cells (MenSCs) …
Rethinking Immunotherapy: A Case for Personalization in Advanced Endometrial Cancer HMP Global Learning Network
Miniature Horse Therapy at Stirling University Brig Newspaper
Endometriosis, a common condition affecting 5-10% of women of reproductive age, is the growth of endometrial-like tissue outside the uterus, leading to pain and infertility. Current treatments, such as surgery …
S2 Episode 4: Immunotherapy Insights and Research in Endometrial Cancer Medscape
Endometriosis is a common cause of subfertility and infertility through myriad mechanisms. Imaging of endometriosis is critical for its diagnosis, characterization, and treatment. Understanding its imaging appearance, surgical management, and …